Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ramkhamhaeng Hospital PCLBKK:RAM-R 73 Future 3-5Y Total Revenue Growth Rate is 14.72 as of Sep. 05, 2026. GuruFocus rates BKK:RAM-R with a GF Score™ of 73/100 and a GF Value™ of ฿42.29. The stock has 6 warning signs investors should review. Among 271 Healthcare Providers & Services companies, Ramkhamhaeng Hospital PCL ranks better than 68.27% on this metric.
Future 3-5Y Total Revenue Growth Rate is the average growth rate of total revenue estimates over a 3-year to 5-year period.
Future 3-5Y Total Revenue Growth Rate is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.
In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.
Ramkhamhaeng Hospital PCL Future 3-5Y Total Revenue Growth Rate Related Terms
BKK:RAM-R vs HCA, THC, EHC: Future 3-5Y Total Revenue Growth Rate Comparison
For the Medical Care Facilities subindustry, Ramkhamhaeng Hospital PCL's Future 3-5Y Total Revenue Growth Rate, along with its competitors' market caps and Future 3-5Y Total Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ramkhamhaeng Hospital PCL Future 3-5Y Total Revenue Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ramkhamhaeng Hospital PCL's Future 3-5Y Total Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where Ramkhamhaeng Hospital PCL's Future 3-5Y Total Revenue Growth Rate falls into.
What does a Future 3-5Y Total Revenue Growth Rate of 14.72 mean?
Ramkhamhaeng Hospital PCL (BKK:RAM-R) has a Future 3-5Y Total Revenue Growth Rate of 14.72 as of Sep. 05, 2026. Total Revenue Growth Rate (Future 3Y To 5Y Est) is the average growth rate of total revenue estimates over a 3-year to 5-year period. View historical data for Ramkhamhaeng Hospital PCL and its competitors. According to the industry distribution chart, Ramkhamhaeng Hospital PCL ranks #86 out of 271 companies in the Healthcare Providers & Services industry, placing it in the top 31.7%.
Is Ramkhamhaeng Hospital PCL's Future 3-5Y Total Revenue Growth Rate too high?
Ramkhamhaeng Hospital PCL's current Future 3-5Y Total Revenue Growth Rate is 14.72. The Healthcare Providers & Services industry median Future 3-5Y Total Revenue Growth Rate is 9.99. Ramkhamhaeng Hospital PCL's value of 14.72 is 47.3% above this industry median. Based on the distribution chart, Ramkhamhaeng Hospital PCL ranks #86 out of 271 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ramkhamhaeng Hospital PCL has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does Ramkhamhaeng Hospital PCL's Future 3-5Y Total Revenue Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ramkhamhaeng Hospital PCL ranks #86 out of 271 companies for Future 3-5Y Total Revenue Growth Rate. This puts Ramkhamhaeng Hospital PCL in the upper half of its industry. The industry median Future 3-5Y Total Revenue Growth Rate is 9.99. Ramkhamhaeng Hospital PCL's value of 14.72 is 47.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Future 3-5Y Total Revenue Growth Rate for a Healthcare Providers & Services company?
The median Future 3-5Y Total Revenue Growth Rate among Healthcare Providers & Services companies is 9.99, based on 271 companies in the industry. Companies in the top quartile (top 25%) have a Future 3-5Y Total Revenue Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, Future 3-5Y Total Revenue Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ramkhamhaeng Hospital PCL's current Future 3-5Y Total Revenue Growth Rate of 14.72 is 47.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Future 3-5Y Total Revenue Growth Rate mean?
A high Future 3-5Y Total Revenue Growth Rate can signal that a stock is expensive relative to its fundamentals. Total Revenue Growth Rate (Future 3Y To 5Y Est) is the average growth rate of total revenue estimates over a 3-year to 5-year period. View historical data for Ramkhamhaeng Hospital PCL and its competitors. For the Healthcare Providers & Services industry, the median Future 3-5Y Total Revenue Growth Rate is 9.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ramkhamhaeng Hospital PCL's current Future 3-5Y Total Revenue Growth Rate is 14.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ramkhamhaeng Hospital PCL stock overvalued right now?
Ramkhamhaeng Hospital PCL (BKK:RAM-R) has a current Future 3-5Y Total Revenue Growth Rate of 14.72. The stock's GF Value™ is ฿42.29, compared to a current price of ฿17.40 — trading 58.9% below its estimated fair value. The current Future 3-5Y Total Revenue Growth Rate is 14.72 and 47.3% above the Healthcare Providers & Services industry median of 9.99. Ramkhamhaeng Hospital PCL's overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Future 3-5Y Total Revenue Growth Rate calculated?
Future 3-5Y Total Revenue Growth Rate is calculated from a company's financial statements. For Ramkhamhaeng Hospital PCL (BKK:RAM-R), the current Future 3-5Y Total Revenue Growth Rate is 14.72 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ramkhamhaeng Hospital PCL (BKK:RAM-R) Overvalued in 2026?
Based on GuruFocus' analysis, Ramkhamhaeng Hospital PCL stock appears to be undervalued.
The current stock price of ฿17.40 is trading 58.9% below its estimated GF Value™ of ฿42.29.
Key valuation signals for BKK:RAM-R:
Future 3-5Y Total Revenue Growth Rate: 14.72
GF Value™: ฿42.29 vs. price of ฿17.40 (58.9% below fair value)
Industry Position: 47.3% above the Healthcare Providers & Services median (#86 of 271)
No single metric tells the full story. See the BKK:RAM-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ramkhamhaeng Hospital PCL business activities are hospital and businesses that support medical care. The company provides medical treatment for all types of diseases by physicians and medical professionals in all specialties. Its medical services include the 24-hour Heart Center, RAM Pituitary Center for laparoscopic surgery for pituitary tumors, Neurology & Neurosurgery Center, and specialized medical centers such as Eye Clinic, Ear, Nose and Throat Clinic, Gastroenterology Clinic, Obstetrics and Gynecology Clinic, and Diabetes Clinic. The company operates through two segments: Hospital, which includes General Hospital and Hospital in Social Security and generates the maximum revenue; and Others, which includes sale of medical equipment and instruments. Its operations are in Thailand.
73GF Score
Get the complete analysis for BKK:RAM-R
Future 3-5Y Total Revenue Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:RAM-R has been successfully added to your 
